¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"neoplasms, multiple primary"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • primary cement
    ÀÏÂ÷½Ã¸àÆ®Áú
  • primary character
    ÀÏÂ÷¼º°Ý
  • primary cholestatic liver disease
    ¿ø¹ß¾µ°³ÁóÁ¤Ã¼°£Áúȯ, ¿ø¹ß´ãÁóÁ¤Ã¼°£Áúȯ
  • primary ciliary dyskinesia
    ¿ø¹ß¼¶¸ð¿îµ¿ÀÌ»óÁõ
  • primary complex
    ¿ø¹ßº¹ÇÕü, Ãʱ⺯ȭ±º
  • primary contact
    ÀÏÂ÷Á¢ÃË
  • primary culture
    ÀÏÂ÷¹è¾ç, óÀ½½É±â
  • primary degenerative dementia
    ¿ø¹ßÅðÇàÄ¡¸Å
  • primary dentin
    ÀÏÂ÷»ó¾ÆÁú
  • primary dentition
    ÀÏÂ÷Ä¡¾Æ
  • primary depression
    ¿ø¹ß¿ì¿ïÁõ
  • primary dysmenorrhea
    ¿ø¹ß¿ù°æÅë
  • primary fissure
    ù°ƴ»õ, ¼Ò³úÁ¦ÀÏ¿­
  • primary focus
    ¿ø¹ßº´ÅÍ
  • primary follicle
    ÀÏÂ÷³­Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • primary cement
    ÀÏÂ÷½Ã¸àÆ®Áú
  • primary character
    ÀÏÂ÷¼º°Ý
  • primary coil
    ÀÏÂ÷ÄÚÀÏ
  • primary complex
    Ãʱ⺯ȭ±º, ¿ø¹ßº¹ÇÕü
  • primary constriction
    (¢¡centromere) ¸Åµì, µ¿¿øÃ¼, Áß½ÉÀý
  • primary contact
    ÀÏÂ÷Á¢ÃË
  • primary culture
    óÀ½½É±â
  • primary biliary cirrhosis
    ¿ø¹ß¾µ°³°ü°£°æÈ­(Áõ)
  • primary health care
    ÀÏÂ÷º¸°ÇÀÇ·á
  • primary inoculation complex
    ¿ø¹ßÁ¢Á¾º¹ÇÕü
  • primary ossification center
    ÀÏÂ÷»ÀµÇ±âÁß½É, ÀÏÂ÷°ñÈ­Áß½É
  • primary sex character
    ÀÏÂ÷¼ºÂ¡
  • delayed primary suture
    Áö¿¬ÀÏÂ÷ºÀÇÕ
  • primary dentin
    ÀÏÂ÷»ó¾ÆÁú
  • primary dentition
    (¢¡deciduous tooth) Á¥´Ï, Å»¶ôÄ¡¾Æ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • primary circuit
    ÀÏÂ÷ȸ·Î(ÊÙÌ·ËÈ).
  • primary coil
    ÀÏÂ÷ÄÚÀÏ.
  • primary color =fundamental c.
    ¿ø»ö (ê«ßä).
  • primary complex
    Ãʱ⺯ȭ±º(ôøÑ¢Ü¨ûùÏØ).
  • primary complex
    Ãʱ⺯ȭ±º(ôøÑ¢Ü¨ûùÏØ)
  • primary constriction
    ÀÏÂ÷ÇùÂø(ìéó­úõó¸).
  • primary culture
    ÃÊ(´ë)¹è¾ç, ÀÏÂ÷¹è¾ç.
  • primary current
    ÀÏÂ÷Àü·ù(¡­ï³êü).
  • primary cutaneous adenocystic carcinoma
    ¿ø¹ß¼º ÇǺΠ¼±³¶Á¾¼º¾Ï
  • primary degeneration
    ÀÏÂ÷º¯¼º(ìéó­Ü¨àõ)
  • primary degenerative dementia
    ÀÏÂ÷¼º¡¡ÅðÇ༺ġ¸Å£¨ìéó­àõ¡¡÷Üú¼àõö¸ţ©£®
  • primary dentin
    ÀÏÂ÷<Á¦ÀÏ>»ó¾ÆÁú.
  • primary dentition
    ÀÏÂ÷<Á¦ÀÏ>»ýÄ¡(ìéó­<ð¯ìé>ßæöÍ).
  • primary depression
    ÀÏÂ÷¼º¡¡¿ì¿ïÁõ(º´)
  • primary dermal ridge
    ÀÏÂ÷ÁøÇǸª(ìéó­òØ ù«×Ò).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • multiple epiphyseal dysplasia
    ´Ù¹ß¼º °ñ´ÜÀÌÇü¼ºÁõ(ÒýÛ¡àõÍéÓ®ì¶û¡à÷ñø).
  • multiple epitheliomatosis
    ´Ù¹ß»óÇÇÁ¾Áõ(Òý Û¡ß¾ù«ðþñø).
  • multiple epitheliomatosis
    ´Ù¹ß»óÇÇÁ¾Áõ(ÒýÛ¡ß¾ù«ðþñø)
  • multiple epitheliomatosis
    ´Ù¹ß»óÇÇÁ¾Áõ(´Ù¹ß»óÇÇÁ¾Áõ).
  • multiple evanescent white dot syndrome
    ´Ù¹ß¼º¼Ò½Ç¼º¹é¹ÝÁõÈıº
  • multiple excitaiton
    ´ÙÁß ¿©±â
  • multiple excitation
    ¹Ýº¹ÈïºÐ(ÚãÜÖýéÝÇ).
  • multiple exostoses =diaphyseal aclasis
    ´Ù¹ß¼º ¿Ü°ñÁõ(¡­ èâÍéñø)
  • multiple exostosis =diaphyseal aclasis
    ´Ù¹ß¼º ¿Ü°ñÁõ(ÒýÛ¡àõèâÍéñø), ´Ù¹ß¼º °ñ¿¬°ñÁ¾(ÒýÛ¡àõÍéæãÍéðþ).
  • multiple fetation
    ´Ù¼öÀÓ½Å(Òýâ¦ìôãã).
  • multiple fibrofolliculoma
    ´Ù¹ß¼º¼¶À¯¸ð³¶Á¾
  • multiple fibrofolliculomas
    ´Ù¹ß¼º ¼¶À¯¸ð³¶Á¾
  • multiple fibroma
    ´Ù¹ß¼º ¼¶À¯Á¾.
  • multiple field irradiation
    ´ÙÁ¶»ç¿µ¿ªÄ¡·á
  • multiple fission
    ´Ù¼öºÐ¿­(Òýâ¦ÝÂæñ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
MS   1) Mitral Stenosis
  2) Multiple Sclerosis; ´Ù¹ß¼º °æÈ­Áõ
  3) Macro...
MSLT Multiple Sleep Latency Test
MODS Multiple Organ Dysfunction Syndrome
AMBER advanced multiple-beam equalization radiography
B-K initials of two patients after whom a multiple cutaneous nevus [mole] was named
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
PCG Primary Care Group
PCP Primary Care Physician
PCT Primary Care Team
PCNSL Primary Central Nervous System Lymphoma
PCD Primary Ciliary Dyskinesia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • primary afferent cell body
    ÀÏÂ÷ ±¸½É¼º ¼¼Æ÷ü
  • primary afferent fiber
    ÀÏÂ÷ ±¸½É ¼¶À¯
  • primary afferent nociceptive transmitter
    ÀÏÂ÷ ±¸½É À¯ÇØ ¼ö¿ë¼º Àü´Þ ¹°Áú
  • primary afferent nociceptor input
    ÀÏÂ÷ ±¸½É¼º Ä§ÇØ¼ö¿ëü ÀÔ·Â, ÀÏÂ÷ ±¸½É¼º À¯Çؼö¿ë±â ÀÔ·Â
  • primary afferent projection
    ÀÏÂ÷ ±¸½É¼º Åõ»ç
  • primary afferent terminal
    ÀÏÂ÷ ±¸½É¼º ¸»´Ü
  • primary amenorrhea
    ¿ø¹ß ¹«¿ù°æ, ¿ø¹ß¼º ¹«¿ù°æ
  • primary amyloidosis
    ¿ø¹ß¼º À¯ÀüºÐÁõ, ¿ø¹ß ¾Æ¹Ð·ÎÀ̵åÁõ, ¿ø¹ß¼º ¾Æ¹Ð·ÎÀ̵åÁõ
  • primary anesthesia
    ÀÏÂ÷ ¸¶Ãë
  • primary benign leukoplakias
    ¿ø¹ß¼º ¾ç¼º ¹é¹ÝÁõ
  • primary bond
    ÀÏÂ÷ °áÇÕ
    ÀϹÝÀûÀ¸·Î À̿ °áÇÕ, °øÀ¯ °áÇÕ, ¹èÀ§ °áÇÕ, ±Ý¼Ó °áÇÕ µîÀ» ¸»ÇÏ¸ç °áÇÕ·ÂÀÌ °¡Àå °­ÇÏ´Ù
  • primary bullous dermatoses
    ¿ø¹ß ¼öÆ÷¼º ÇǺκ´
  • primary carcinoma
    ¿ø¹ß ¾ÏÁ¾
  • primary cement
    ÀÏÂ÷ ½Ã¸àÆ®Áú, Á¦ÀÏ ½Ã¸àÆ®Áú
  • primary cephalic vein
    ÀÏÂ÷ ¸Ó¸® Á¤¸Æ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
multiple trauma Physical insults or injuries occurring simultaneously in several parts of the body.
(12 Dec 1998)
multiple vision polyopia
hamartoma syndrome, multiple A hereditary disease characterised by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Papules of the face and oral mucosa are the most characteristic lesion. Other changes occur in the skin, in the thyroid, the breast, the gastrointestinal system, and the nervous system.
(12 Dec 1998)
pregnancy, multiple The condition of bearing two or more foetuses simultaneously.
(12 Dec 1998)
hereditary multiple exostoses A disturbance of enchondral bone growth in which multiple, generally benign osteochondromas of long bones appear during childhood, commonly with shortening of the radius and fibula; the ill-effects are usually mechanical but malignant change is rare; autosomal dominant inheritance.
Synonym: diaphysial aclasis, hereditary deforming chondrodystrophy, multiple exostosis, osteochondromatosis.
(05 Mar 2000)
hereditary multiple trichoepithelioma <tumour> Multiple small benign nodules, occurring mostly on the skin of the face, derived from basal cells of hair follicles enclosing small keratin cysts; frequent autosomal dominant inheritance.
Synonym: acanthoma adenoides cysticum, Brooke's tumour, epithelioma adenoides cysticum, hereditary multiple trichoepithelioma.
Origin: tricho-+ epithelioma
(05 Mar 2000)
sclerosis, multiple The National Multiple Sclerosis Society says of ms that it is a disease that randomly attacks your central nervous system, wearing away the control you have over your body. Symptoms may range from numbness to paralysis and blindness. The progress, severity and specific symptoms cannot be foreseen. You never know when attacks will occur, how long they will last, or how severe they will be. most people are diagnosed with ms between the ages of 20 and 40. In medical terms, ms involves demyelinization of the white matter sometimes extending into the gray matter. Demyelinization is loss of myelin, the coating of nerve fibres composed of lipids (fats) and protein that serves as insulation and permits efficient nerve fibre conduction. The white matter is the part of the brain which contains myelinated nerve fibres and appears white, whereas the gray matter is the cortex of the brain which contains nerve cell bodies and appears gray. When myelin is damaged in ms, nerve fibre conduction is faulty or absent. Impaired bodily functions or altered sensations associated with those demyelinated nerve fibres give rise to the symptoms of ms. Recent research (1998) has also identified nerve cell death as part of the nervous system injury in ms.
(12 Dec 1998)
psychotherapy, multiple The use of more than one therapist at one time in individual or group psychotherapy.
(12 Dec 1998)
drug resistance, multiple Simultaneous resistance to a broad spectrum of structurally and functionally distinct drugs following exposure to a single agent. It is thought to result from the overexpression of genes encoding an integral plasma membrane protein, p-glycoprotein.
(12 Dec 1998)
exostoses, multiple hereditary Hereditary disorder transmitted by an autosomal dominant gene and characterised by multiple exostoses (multiple osteochondromas) near the ends of long bones. The genetic abnormality results in a defect in the osteoclastic activity at the metaphyseal ends of the bone during the remodeling process in childhood or early adolescence. The metaphyses develop benign, bony outgrowths often capped by cartilage. A small number undergo neoplastic transformation.
(12 Dec 1998)
familial multiple endocrine adenomatosis The presence of functioning tumours in more than one endocrine gland, commonly the pancreatic islets and parathyroid glands, which may be associated with Zollinger-Ellison syndrome; dominant inheritance.
Synonym: multiple endocrine adenomatosis.
(05 Mar 2000)
law of multiple proportions The relative weights in which two substances form a chemical union singly with a third are the same as, or simple multiples of, those in which they unite with each other; a corollary of the law of definite proportions.
Synonym: law of multiple proportions.
(05 Mar 2000)
lipomatosis, multiple symmetrical Multiple circumscribed or encapsulated lipomas which may be distributed symmetrically or haphazardly or which may form a collar around the neck.
(12 Dec 1998)
bladder neoplasms Cancers or tumours of the bladder. The majority of bladder neoplasms are of the transitional cell variety and are usually papillary and multicentric.
(12 Dec 1998)
bone marrow neoplasms Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as myeloma. most bone marrow neoplasms are metastatic.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á